IRWD logo

IRONWOOD PHARMACEUTICALS INC

IRWDNASDAQ
🏆 #2261 by market capEarnings Nov 9US Equity
$4.30▲ $0.27 (+6.17%)
Market closed · at close
1h—
24h▲ 6.2%
7d▲ 4.1%
14d▲ 21.0%
30d▲ 2.0%
1y▲ 341.3%
🏦Market Cap
$708M
Small Cap
📈Revenue Growth (YoY)
+13.8%
Healthy
📊Gross Margin
100.0%
High
💵FCF Margin
35.2%
Strong
⚖️P/S Ratio
1.9x
Cheap
Otter Score
56
Weak
📊

Analyst Ratings

Price
$4.30
Total
30
Raised
7
Lowered
5
Avg PT
$3.70
H / L
$4 / $4
InstitutionActionRatingDate
Citizens
ReiteratedMarket Outperform2026-02-26
Wells Fargo
ReiteratedEqual Weight2026-01-05
Jefferies
DowngradedBuy → Hold2025-04-15
Leerink Partners
ReiteratedMarket Perform2025-04-14
JMP Securities
ReiteratedMarket Outperform2025-01-30
Craig-Hallum
ReiteratedBuy2025-01-22
Piper Sandler
ReiteratedOverweight2024-02-16
Morgan Stanley
ReiteratedEqual Weight2021-10-12
Credit Suisse
ReiteratedNeutral2020-11-06
HC Wainwright & Co.
ReiteratedNeutral2020-05-11
H.C. Wainwright
UpgradedSell → Neutral2019-02-25
JP Morgan
UpgradedUnderweight → Neutral2019-01-24
Cowen & Co.
DowngradedOutperform → Market Perform2018-07-18
Barclays
ReiteratedEqual Weight2018-05-03
Mizuho
UpgradedNeutral → Buy2018-05-02
Bank of America
DowngradedBuy → Underperform2018-01-05
B of A Securities
DowngradedBuy → Underperform2018-01-05
Goldman Sachs
ReiteratedNeutral2016-03-21
BTIG Research
ReiteratedBuy2015-12-11
Leerink Swann
ReiteratedMarket Perform2015-05-05
Cantor Fitzgerald
UpgradedSell → Hold2015-02-06
Furey Research
ReiteratedBuy2014-07-09
Wallachbeth
ReiteratedHold2014-06-18
BMO Capital
ReiteratedMarket Perform → Perform2013-09-23
Janney Capital
UpgradedNeutral → Buy2013-07-24
Janney Montgomery Scott
UpgradedNeutral → Buy2013-07-24
Wedbush
UpgradedUnderperform → Neutral2013-05-30
Aegis Capital
ReiteratedBuy2013-04-23
UBS
DowngradedNeutral → Sell2013-01-16
Ladenburg Thalmann
ReiteratedBuy2012-05-01
One row per institution, most recent rating